This proposal addresses an RFA # RFA-RM-04-009 initiated by NIH for development of a Center for innovation in membrane protein production. We focus exclusively on eukaryotic membrane proteins since they constitute approximately 30% of all eukaryotic proteins and are targets for over 40% of all drugs in use today, yet there is little understanding of the mechanisms, atomic interactions of these, or even which protein is the target for today's drugs in many cases. Subprojects, each directed by one, or two expert Co-Principle Investigators address eight novel expression systems that will be developed and applied first to strategically selected eukaryotic membrane proteins. These systems range from applying new strategies to prokaryotic expression in E. coli, utilizing L. lactis, utilizing strains of Yeast with expanded endoplasmic reticulum, taking advantage of new technology for suspension culture [and thus higher density] of HEK cells, to the development of a completely novel eukaryotic system, Chlorella. The center will provide continuous assessment of each expression method in its application to each membrane protein, or membrane protein class. Target proteins are used first to establish and calibrate the expression methods. The goal is that the center will ultimately provide access to NIH funded investigators who may arrange to express certain membrane proteins through the center, or who may obtain protocols for application of center methods for their own applications to expression. As expression schemes are evolved and pruned they will each be applied to each membrane protein that enters the center, to select the most efficacious scheme. That method will then be applied to 'industrialized' (meaning standardized, and optimized for routine) expression of that membrane protein. Subprojects also address novel schemes for purification and characterization that have been established as highly successful in initial applications, enhancement of stability of membrane proteins, and generation of, and affinity maturation of antibodies as they may be required for certain applications including some aspects of purification, co-crystallizations, and characterizations. A plan for in vitro production of membrane proteins is to be phased in as the center becomes established. A plan for dissemination of the information gained, up to date results with each novel expression method, purification status with each membrane protein via web access is presented.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center (P50)
Project #
1P50GM073210-01
Application #
6875366
Study Section
Special Emphasis Panel (ZGM1-CMB-0 (MP))
Program Officer
Preusch, Peter C
Project Start
2004-09-24
Project End
2009-07-31
Budget Start
2004-09-24
Budget End
2005-07-31
Support Year
1
Fiscal Year
2004
Total Cost
$2,285,056
Indirect Cost
Name
University of California San Francisco
Department
Biochemistry
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Metcalf, Brian; Chuang, Chihyuan; Dufu, Kobina et al. (2017) Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin. ACS Med Chem Lett 8:321-326
Dang, Bobo; Wu, Haifan; Mulligan, Vikram Khipple et al. (2017) De novo design of covalently constrained mesosize protein scaffolds with unique tertiary structures. Proc Natl Acad Sci U S A 114:10852-10857
Li, Zhe; Partridge, James; Silva-Garcia, Abel et al. (2017) Structure-Guided Design of Novel, Potent, and Selective Macrocyclic Plasma Kallikrein Inhibitors. ACS Med Chem Lett 8:185-190
Zhou, X Edward; Gao, Xiang; Barty, Anton et al. (2016) X-ray laser diffraction for structure determination of the rhodopsin-arrestin complex. Sci Data 3:160021
Schumacher, Maria A; Lee, Jeehyun; Zeng, Wenjie (2016) Molecular insights into DNA binding and anchoring by the Bacillus subtilis sporulation kinetochore-like RacA protein. Nucleic Acids Res 44:5438-49
Rowe, Timothy B; Luo, Zhe-Xi; Ketcham, Richard A et al. (2016) X-ray computed tomography datasets for forensic analysis of vertebrate fossils. Sci Data 3:160040
Kaback, H Ronald (2015) A chemiosmotic mechanism of symport. Proc Natl Acad Sci U S A 112:1259-64
Caffrey, Martin (2015) A comprehensive review of the lipid cubic phase or in meso method for crystallizing membrane and soluble proteins and complexes. Acta Crystallogr F Struct Biol Commun 71:3-18
Huang, Chia Ying; Olieric, Vincent; Ma, Pikyee et al. (2015) In meso in situ serial X-ray crystallography of soluble and membrane proteins. Acta Crystallogr D Biol Crystallogr 71:1238-56
Fowler, Philip W; Orwick-Rydmark, Marcella; Radestock, Sebastian et al. (2015) Gating topology of the proton-coupled oligopeptide symporters. Structure 23:290-301

Showing the most recent 10 out of 123 publications